Read more

September 28, 2020
2 min read
Save

Some alternative therapies may be beneficial in IBS

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Some complimentary alternative therapies, including herbal and dietary supplements, may help ease abdominal pain and benefit overall response in patients with irritable bowel syndrome, according to study results.

Perspective from Ari Garber, MD, EdD

Andrea Shin, MD, of the Indiana University School of Medicine, and colleagues wrote that patients with IBS often seek complimentary alternative therapies (CAMs), whether they are satisfied with conventional medication or not, and their physicians should be prepared to advise them.

“It is important for physicians to understand the evidence behind CAM in order to appropriately counsel patients on their use,” they wrote. “To clarify the clinical utility of CAM for management of IBS, critical assessment of the available evidence that exists on this topic is required.”

Investigators searched the literature for randomized controlled trials that studied CAMs, including herbal therapy, dietary supplements, mind-body based, body based and energy healing, in patients with IBS compared with placebo or sham therapy. They analyzed the data to obtain pooled estimates of mean improvement in abdominal pain (standardized mean difference [SMD]) and relative risk of overall response.

Researchers included data from 66 studies in their analysis.

Shin and colleagues found that herbal therapy demonstrated a benefit over placebo for abdominal pain (SMD = 0.47; 95% CI, 0.2–0.75). However, their confidence in the estimates was low. Mind-body based therapy also showed a borderline benefit over placebo (SMD = 0.29; 95% CI, -0.01 to 0.59).

Researchers also found that herbal therapy (RR = 1.57; 95% CI, 1.31-1.88), dietary supplements (RR = 1.95; 95% CI, 1.02-3.73) and mind-body based therapy (RR = 1.67; 95% CI, 1.13-2.49) showed a benefit for overall response compared with placebo.

“It would be beneficial for future studies to adopt the FDA’s guidance on pharmaceutical treatments for IBS,” Shin and colleagues wrote. “Further work on CAM in IBS should be pursued to maximize therapeutic options, increase CAM awareness among clinicians, and respond to patients’ needs and experiences in IBS.”